p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis

British Journal of Haematology

Volumn 99, Issue 4, 1997, Pages 848-857

  Lens, Daniela ^a   Dyer, Martin J S ^a   Garcia Marco, Jose M ^a   De Schouwer, Pierre J J C ^a   Hamoudi, Rifat A ^a   Jones, David ^a   Farahat, Nahla ^a   Matutes, Estella ^a   Catovsky, Daniel ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; CLL PL; P53; Trisomy 12

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; DNA; FLUDARABINE; KI 67 ANTIGEN; NUCLEOSIDE ANALOG; PENTOSTATIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE ACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MICROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTE; PROTEIN EXPRESSION; TRISOMY; TRISOMY 12; TUMOR GROWTH;

EID: 0031442979     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4723278.x     Document Type: Article

References (52)

1. Baldini, L., Fracchiolla, N.S., Cro, L.M., Trecca, D., Romitti, L., Polli, E., Maiolo, A.T. & Neri, A. (1994) Frequent p53 gene involvement in splenic-cell leukemia/lymphomas of possible marginal zone origin. Blood, 84, 270-278.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1989) French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. Journal of Clinical Pathology, 42, 567-584.
3. Binet, J.L., Lepoprier, M., Dighiero, G., Charron, D., D'Athis, P., Vaugier, G., Beral, H.M., Natali, J.C., Raphael, M., Nizet, B. & Follezou, J.Y. (1977) A clinical staging system for chronic lymphocytic leukemia: prognostic significance, Cancer, 40, 855-864.
4. Bird, M.L., Ueshima, Y., Rowley, J.D., Haren, J.M. & Vardiman, J.W. (1989) Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia, 3, 182-191.
5. Cariello, N.F., Beroud, C. & Soussi, T. (1994) Database and software for the analysis of mutations at the human p53 gene. Nucleic Acids Research, 22, 3549-3550.
6. Casey. G., Plummer, S., Hoeltge, G., Scanlon, D., Fasching, C. & Stanbridge, E.J. (1993) Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Human Molecular Genetics, 2, 1921-1927.
7. Cogen, P.H., Daneshvar, L., Metzger, A.K., Duyk, G., Edwards, M. & Sheffield, V.C. (1992) Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. American Journal of Human Genetics, 50, 584-589.
8. Cordone, I., Matutes, E. & Catovsky, D. (1992) Characterization of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67. Journal of Clinical Pathology, 45, 201-205.
9. Cornelis, R., van Vliet, M., Vos. C., Cleton-Jansen, A., van de Vijver, M., Peterse, J., Meera Khan, P., Borrensen, A., Cornelisse, C. & Devilee, P. (1994) Evidence for a gene on 17p13.3, distal to TP53, as a targent for allele loss in breast tumours without p53 mutations. Cancer Research, 54, 4200-4206.
10. Criel, A., Wlodarska, I., Meeus, P., Stul, M., Louwagie, A., Van-Hoof, A., Hidajat, M., Mecucci, C. & Van-den-Berghe, H. (1994) Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. British Journal of Haematology, 87, 523-528.
11. de-Melo, N., Matutes, E., Cordone, I., Morilla, R. & Catovksy, D. (1992) Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. Journal of Clinical Pathology, 45, 660-663.
12. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C. & Levine, A.J. (1995) Gain of function mutations in p53. Nature Genetics, 4, 42-46.
13. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Bonner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and nonresponse to therapy with purine analogues in chronic B-cell leukemias. Blood, 85, 1580-1589.
14. Donehower, L.A. (1996) Effects of p53 mutation on tumour progression: recent insights from mouse tumour models. Biochimica et Biophysica Acta, 1242, 171-176.
15. Du, M., Peng, H., Singh, N., Isaacson, P.G. & Pan, L. (1995) The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood, 86, 4587-4593.
16. Dyer, M.J.S., Heward, J.M., Zani, V.J., Buccheri, V. & Catovsky, D. (1993) Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias. Blood, 82, 865-871.
17. El Rouby, S., Thomas, A., Costin, D., Rosenberg, C.R., Potmesil, M., Silber, R. & Newcomb, E.W. (1995) p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug-resistance and is independent of mdr1/mdr3 gene expression. Blood, 82, 3452-3459.
18. Fenaux, P., Preudhomme, C., Lai, J.L., Quiquandon, I., Jonveaux, P., Vanrumbeke, M., Sartiaux, C., Morel, P., Loucheux-Lefebvre, M.H., Bauters, F., Berger, R. & Kerckaert, J.P. (1992) Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia, 6, 246-250.
19. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. & Dalla-Favera, R. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 88, 5413-5417.
20. Gaidano, G., Newcomb, E.W., Gong, J.Z., Tassi, V., Neri, A., Cortelezzi, A., Calori, R., Baldini, L. & Dalla-Favera, R. (1994) Analysis of alterations of oncogenes and tumor-suppressor genes in chronic lymphocytic-leukemia. American Journal of Pathology, 144, 1312-1319.
21. Garcia-Marco, J.A., Price, C.M., Ellis, J., Morey, M., Matutes, E., Lens, D., Colman, S. & Catovsky, D. (1996) Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia, 10, 1705-1711.
22. Halevy, O., Michalovitz, D. & Oren, M. (1990) Different tumor-derived p53 mutants exhibit distinct biological activities. Science, 250, 113-116.
23. Hall, P.A., Ray, A., Lemoine, N.R., Midgley, C.A., Krausz, T. & Lane, D.P. (1991) p53 immunostaining as a marker of malignant disease in diagnostic cytopathology Lancet, 338, 513.
24. Harris, C.C. & Hollstein, M. (1993) Clinical implications of the p53 tumor suppressor gene. New England Journal of Medicine, 329, 1318-1327.
25. Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. & Harris, C.C. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Research, 22, 3551-3555.
26. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
27. Imamura, J., Miyoshi, I. & Koeffler, H.P. (1994) p53 in hematologic malignancies. Blood, 84, 2412-2421.
28. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W. & Vogelstein, B. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
29. Kocialkowsky, S., Pezzella, P., Morrison, H., Jones, M., Laha, S., Harris, A.L., Mason, D.Y. & Gatter, K.C. (1995) Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 expression in high-grade non-Hodgkin's lymphoma. British Journal of Haematoloay, 89, 55-60.
30. Kondoleon, S., Vissing, H., Luo, X.Y., Magenis, R.E., Kellogg, J. & Litt, M. (1987) A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 [HGM9 No. D17S34]. Nucleic Acids Research. 15, 10605.
31. Lens, D., De Schouwer, P., Hamoudi, R., Abdul-Rauf, M., Farahat, N., Matutes, E., Crook, T., Dyer, M. & Catovsky, D. (1997) p53 abnormalities in B-cell prolymphocytic leukemia. Blood, 89, 2015-2023.
32. Lo Coco, F., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S.K. & Dalla-Favera, R. (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood, 82, 2289-2295.
33. Makos Wales, M., Biel, M.A., El Deiry, W, Nelkin, B.D., Issa, J.P., Cavenne, W.K., Kuerbitz, S.J. & Baylin, S.B. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Medicine, 1, 570-577.
34. Mason, D., Cordell, J., Abdulaziz, A., Naiem, M. & Bordenave, G. (1982) Preparation of peroxidase anti-peroxidase (PAP) complexes for immunohistological labelling of monoclonal antibodies. Journal of Histochemistry and Cytochemistry, 11, 1114-1122.
35. Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G.J. & Catovsky, D. (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. British Journal of Haematology, 92, 382-388.
36. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia-Marco, J., Houlihan, A., Que, T.H. & Catovsky, D. (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640-1645.
37. Melo, J.V., Catovsky, D. & Galton, D.A. (1986) The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia, I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. British Journal of Haematology, 63, 377-387.
38. Melo, J.V., Catovsky, D., Gregory, W.M. & Galton, D.A. (1987) The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. British Journal of Haematology, 65, 23-29.
39. Milner, J., Medcalf, E.A. & Cook, A.C. (1991) Tumor suppressor p53: analysis of wild-type and mutant p53 complexes, Molecular Cell Biology, 11, 12-19.
40. Nakamura, Y., Ballard, L., Leppert, M., O'Connell, P.O., Lathrop, G.M., Lalouel, J.-M. & White, R. (1988) Isolation and mapping of a polymorphic DNA sequence (PYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Research, 16, 570.
41. Newcomb, E.W. (1995) p53 gene-mutations in lymphoid diseases and their possible relevance to drug-resistance. Leukemia and Lymphoma, 17, 211-221.
42. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hosteller, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C. & Volgenstein. B. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705.
43. Piris, M.A., Villuendas, R., Martinez, J.C., Sanchez-Beato, M., Orradre, J.L., Mateo, M.S. & Martinez, P. (1995) p53 expression in non-hodgkins-lymphomas: a marker of p53 inactivation? Leukemia and Lymphoma, 17, 35-42.
44. Que, T.H., Marco, J.G., Ellis, J., Matutes, E., Babapulle, V.B., Boyle, S. & Catovsky, D. (1993) Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood, 82, 571-575.
45. Scott, C.S., Limbert, H.J., Roberts, B.E. & Stark, A.N. (1987) Prolymphocytoid variants of chronic lymphocytic leukaemia: an immunological and morphological survey, Leukemia Research, 11, 135-140.
46. Soussi, T., Legros, Y., Lubin, R., Ory, K. & Schlichtholz, B. (1994) Multifactorial analysis of p53 alteration in human cancer: a review. International Journal of Cancer, 57, 1-9.
47. Trump, D.L., Mann, R.B., Phelps, R., Roberts, H. & Conley, C.L. (1980) Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia: a report of five cases and review of the literature. American Journal of Medicine, 68, 539-548.
48. Vallespi, T., Montserrat, E. & Sanz, M.A. (1991) Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes: a multivariate survival analysis in 146 patients. British Journal of Haematology, 77, 478-485.
49. Villuendas, R., Piris, M.A., Orradre, J.L., Mollejo, M., Algara, P., Sanchez, L., Martinez, J.C. & Martinez, P. (1992) p53 protein expression in lymphomas and reactive lymphoid-tissue. Journal of Pathology, 166, 235-241.
50. Wada, M., Bartram, C.R., Nakamura, H., Hachiya, M., Chen, D.L., Borenstein, J., Miller, C.W., Ludwig, L., Hansen-Hagge, T.E., Ludwig, W.D., Reiter, A., Mizoguchi, H. & Koefller, H.P. (1993) Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood. 82, 3163-3169.
51. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. & Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157.
52. Wynford-Thomas, D. (1992) p53 in tumour pathology: can we trust immunocytochemistry? Journal of Pathology, 166, 329-330.